PACTR201408000873384尚未招募未知
Extension to study MALARIA-055 PRI (NCT00866619) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals candidate malaria vaccine (SB257049) in infants and children in Africa.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 4,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 42 Month(s) 至 9 Year(s)（—）
- 性别
- All
入选标准
- •Subjects parent(s)/ Legally Acceptable Representative (LARs) who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
- •- Subjects who were enrolled and who received at least one vaccine dose in the primary study MALARIA-055 PRI NCT00866619 and who did not withdraw consent (except those who moved away from the area) during the primary study MALARIA-055 PRI NCT00866619.
- •- Written informed consent obtained from the parent(s)/LAR(s) of the subject.
排除标准
- •- Child in care.
- •- Use of any investigational or non-registered product or planned use during the study period.
研究者
相似试验
尚未招募
2 期
Severe Malaria A Research and Trials consortium - Multisite Adaptive Platform trialMalariaPACTR202312551082722Imperial College450
进行中（未招募）
Unknown
Severe malaria in African children: A randomised clinical trial with an adaptive desigSevere malariaInfections and InfestationsISRCTN79071535Imperial College London450
已完成
不适用
REMEDI study: Improving malaria diagnosis and treatment in NigeriaISRCTN12605216niversity of California, San Francisco (USA)1,500
已完成
不适用
Increasing malaria diagnosis in the private sector in TanzaniaInfections and InfestationsMalariaISRCTN14115509Clinton Health Access Initiative1,500
尚未招募
2 期
A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )Plasmodium Vivax InfectionMalaria VaccineNCT05380388University of Oxford36